Table of Contents           

Chapter 1.           Research Scope & Methodology

1.1          Market Definition

1.2          Market Breakdown by Type of Tests, Sample

1.3          Market Breakdown by Geography

1.4          Research Methodology and Sources

Chapter 2.           Executive Summary

2.1          Key Findings

2.2          Research Summary

Chapter 3.           Market Outlook

3.1          Introduction

3.1.1      International Drug Trafficking

3.1.2      Drug trafficking and illicit drug use in North America

3.1.3      Drug trafficking and illicit drug use in Europe

3.1.4      Drug trafficking and illicit drug use in Asia-Pacific

3.2          Technology Analysis – Drug Abuse Testing Market

3.2.1      Chromatography technology

3.2.2      Immunoassay technology

3.3          Single vis-à-vis Multiple Parameter Test

3.4          Factors Driving the Market and its Impact on Market Forecast

3.4.1      Increased use of drug testing at organizational level

3.4.2      Increased production and trade of illicit drugs worldwide

3.4.3      Global increase in road accidents and death rates

3.4.4      Increase in the consumption of illegal drugs

3.4.5      Impact analysis of drivers on market forecast

3.5          Factors Hindering the Market and its Impact on Market Forecast

3.5.1      Legalization of drugs

3.5.2      Social issues associated with drug abuse testing

3.5.3      Inability of testing products to detect low-dose designer drugs

3.5.4      Impact analysis of restraints on market forecast

Chapter 4.           Global Market Size & Forecast (2011-2020)

4.1          Global Market Breakdown by Type of Test

4.2          Global Market Breakdown by Sample

4.3          Global Market Breakdown by Region

Chapter 5.           Global Market Breakdown by Type of Test

5.1          Onsite Testing

5.2          Laboratory Testing

5.3          The North American Market by Type of Test

5.3.1      U.S. drugs of abuse market by type of test

5.4          The European Market by Type of Test

5.4.1      The U.K. drugs of abuse market, by type of test

5.4.2      Germany drugs of abuse market by type of test

5.4.3      France drugs of abuse market, by type of test

5.5          The Asian Market by Type of Test

5.5.1      India drugs of abuse market by type of test

5.5.2      China drugs of abuse market, by type of test

5.5.3      Japan drugs of abuse market, by type of test

Chapter 6.           Global Market Breakdown by Sample

Chapter 7.           Global Market Breakdown by Region

7.1          North America Market Breakdown by Country

7.1.1      Drug abuse market scenario in the U.S.

7.2          Europe Market Breakdown by Country

7.2.1      Drug abuse market scenario in the U.K.

7.2.2      Drug abuse market scenario in France

7.2.3      Drug abuse market scenario in Germany

7.3          Asia-Pacific Market Breakdown by Country

7.3.1      Drug abuse market scenario in India

7.3.2      Drug abuse market scenario in China

7.3.3      Drug abuse market scenario in Japan

Chapter 8.           Competitive Analysis and Market Share

8.1          Porter's Five Forces of Competitive Position Analysis

8.1.1      Bargaining power of buyers

8.1.2      Bargaining power of suppliers

8.1.3      Threat of new entrants

8.1.4      Intensity of rivalry

8.1.5      Threat of substitutes

Chapter 9.           Company Profiles

9.1          Roche Holding Limited

9.1.1      Business Overview

9.1.2      Products and Services

9.1.3      Recent Developments

9.2          Quest Diagnostics

9.2.1      Business Overview

9.2.2      Products and Services

9.2.3      Recent Developments

9.3          Laboratory Corporation of America Holdings

9.3.1      Business Overview

9.3.2      Products and Services

9.3.3      Recent Developments

9.4          Alere Inc.

9.4.1      Business Overview

9.4.2      Products and Services

9.4.3      Recent Developments

9.5          Abbott Laboratories

9.5.1      Business Overview

9.5.2      Products and Services

9.5.3      Recent Developments

9.6          Randox Laboratories Ltd

9.6.1      Business Overview

9.6.2      Products and Services

9.6.3      Recent Developments

9.7          Psychemedics Corporation

9.7.1      Business Overview

9.7.2      Products and Services

9.7.3      Recent Developments

9.8          Bio-Rad Laboratories, Inc.

9.8.1      Business Overview

9.8.2      Products and Services

9.8.3      Recent Developments

9.9          Sonic Healthcare

9.9.1      Business Overview

9.9.2      Products and Services

9.9.3      Recent Developments

9.1          Thermo Fisher Scientific Inc.

9.10.1    Business Overview

9.10.2    Products and Services

9.10.3    Recent Developments

Chapter 10.         Appendix

10.1        List of Abbreviations

List of Tables    

TABLE 1                                SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2                                GLOBAL DRUG ABUSE TESTING MARKET SNAPSHOT        (2015AND 2020)

TABLE 3                                WORLDWIDE NUMBER OF ILLICIT DRUG USERS, BY MAJOR DRUGS, % SHARE       (2011)

TABLE 4                                MULTIPLE PARAMETER TEST ADVANTAGES OVER SINGLE PARAMETER TEST

TABLE 5                                DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6                                RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 7                                GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 8                                GLOBAL MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 9                                GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2011 – 2014)

TABLE 10              GLOBAL MARKET BREAKDOWN BY SAMPLE, $M (2015 – 2020)

TABLE 11              GLOBAL MARKET BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 12              GLOBAL MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 13              ONSITE SCREENING TEST – ADVANTAGES AND DISADVANTAGES

TABLE 14              LABORATORY DRUG TEST - ADVANTAGES AND DISADVANTAGES

TABLE 15              NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 16              NORTH AMERICA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 17              U.S. MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 18              U.S. MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 19              EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 20              EUROPE MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 21              THE U.K.  MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 22              THE U.K.  MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 23              GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 24              GERMANY MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 25              FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 26              FRANCE MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 27              ASIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 28              ASIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 29              INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 30              INDIA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 31              CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 32              CHINA MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 33              JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2011 – 2014)

TABLE 34              JAPAN MARKET BREAKDOWN BY TYPE OF TEST, $M (2015 – 2020)

TABLE 35              SAMPLE ANALYSIS – ADVANTAGES AND DISADVANTAGES

TABLE 36              NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 37              NORTH AMERICA MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 38              EUROPE MARKET BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 39              EUROPE MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 40              ASIA MARKET BREAKDOWN BY REGION, $M (2011 – 2014)

TABLE 41              ASIA MARKET BREAKDOWN BY REGION, $M (2015 – 2020)

TABLE 42              ROCHE HOLDINGS – KEY FACTS

TABLE 43              QUEST DIAGNOSTICS – KEY FACTS

TABLE 44              LABORATORY CORPORATION OF AMERICA HOLDINGS – KEY FACTS

TABLE 45              ALEREINC. – KEY FACTS

TABLE 46              ABBOTT LABORATORIES – KEY FACTS

TABLE 47              RANDOX LABORATORIES – KEY FACTS

TABLE 48              PSYCHEMEDICS CORPORATION – KEY FACTS

TABLE 49              BIO-RAD LABORATORIES – KEY FACTS

TABLE 50              SONIC HEALTHCARE – KEY FACTS

TABLE 51              THERMO FISHER SCIENTIFIC INC.– KEY FACTS

List of Figures   

FIG 1      GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2014)

FIG 2      GLOBAL DRUG ABUSE TESTING MARKET SHARE BY SAMPLE (2014)

FIG 3      GLOBAL DRUG ABUSE TESTING MARKET SHARE BY REGION (2014)

FIG 4      GLOBAL DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2014)

FIG 5      THE NORTH AMERICAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015)

FIG 6      THE EUROPEAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST (2015)

FIG 7      THE ASIAN DRUG ABUSE TESTING MARKET SHARE BY TYPE OF TEST, 2015

FIG 8      GLOBAL DRUG ABUSE TESTING MARKET SHARE, BY SAMPLE, 2015

FIG 9      NORTH AMERICA DRUG ABUSE TESTING MARKET SHARE BY COUNTRY   (2014)

FIG 10   EUROPE DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014)

FIG 11   ASIA-PACIFIC DRUG ABUSE TESTING MARKET SHARE BY COUNTRY (2014)

FIG 12   PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS